by Peter Dettmar | Aug 4, 2019 | Company News, pepsin
An evaluation of the current literature on pepsin from its discovery and structure to the comparison of concentration between adults and newborns has recently been published in the internationally peer reviewed journal EC Gastroenterology and Digestive System (ECGDS).... 
by rdbiomed | Feb 6, 2019 | Company News
RD Biomed is delighted to introduce the new Peptest packaging and instructions designed to enrich our customer’s experience and make reflux home testing easier than ever. Peptest is an accurate, painless and inexpensive test that measures the presence of stomach... 
by rdbiomed | Dec 6, 2018 | Company News
Biohit Healthcare, the distributor for Peptest in the UK and Ireland, exhibited at a British Laryngological Association study day this month. (Pictured at the event is Andrew Woodcock, laboratory manager at RD Biomed, with surgeon Mark Watson). The one-day meeting was... 
by rdbiomed | Dec 3, 2018 | Company News
RD Biomed and the Peptest team headed to the Czech Republic’s largest pulmonary disease conference in Pilsen in early November. The three-day IV. Kongres České pneumologické a ftizeologické společnosti ČLS Plzen included parallel speaker sessions, poster presentations... 
by rdbiomed | Nov 5, 2018 | Company News
We recently teamed up with video production company Pixelwave Creative to create a helpful step-by-step video guide for medical professionals using Peptest. The Peptest kit is an immunological in-vitro diagnostic medical device that contains two pepsin monoclonal... 
by rdbiomed | Oct 22, 2018 | Company News, pepsin
Gastroesophageal reflux disease (GERD) has been a common disease in Western countries for many years but population studies have always indicated a lower prevalence in Asian countries. But a new large-scale study across Shanghai and Beijing in China has revealed the...
Recent Comments